Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease

Fang Chen, Wenqing Su, Shawn H Becker, Mike Payne, Cynthia M Castro Sweet, Anne L Peters, Timothy M Dall, Fang Chen, Wenqing Su, Shawn H Becker, Mike Payne, Cynthia M Castro Sweet, Anne L Peters, Timothy M Dall

Abstract

Background: Type 2 diabetes and cardiovascular disease impose substantial clinical and economic burdens for seniors (age 65 and above) and the Medicare program. Intensive Behavioral Counseling (IBC) interventions like the National Diabetes Prevention Program (NDPP), have demonstrated effectiveness in reducing excess body weight and lowering or delaying morbidity onset. This paper estimated the potential health implications and medical savings of a digital version of IBC modeled after the NDPP.

Methods and findings: Participants in this digital IBC intervention, the Omada program, include 1,121 overweight or obese seniors with additional risk factors for diabetes or heart disease. Weight changes were objectively measured via participant use of a networked weight scale. Participants averaged 6.8% reduction in body weight within 26 weeks, and 89% of participants completed 9 or more of the 16 core phase lessons. We used a Markov-based microsimulation model to simulate the impact of weight loss on future health states and medical expenditures over 10 years. Cumulative per capita medical expenditure savings over 3, 5 and 10 years ranged from $1,720 to 1,770 (3 years), $3,840 to $4,240 (5 years) and $11,550 to $14,200 (10 years). The range reflects assumptions of weight re-gain similar to that seen in the DPP clinical trial (lower bound) or minimal weight re-gain aligned with age-adjusted national averages (upper bound). The estimated net economic benefit after IBC costs is $10,250 to $12,840 cumulative over 10 years. Simulation outcomes suggest reduced incidence of diabetes by 27-41% for participants with prediabetes, and stroke by approximately 15% over 5 years.

Conclusions: A digital, remotely-delivered IBC program can help seniors at risk for diabetes and cardiovascular disease achieve significant weight loss, reduces risk for diabetes and cardiovascular disease, and achieve meaningful medical cost savings. These findings affirm recommendations for IBC coverage by the U.S. Preventive Services Task Force.

Conflict of interest statement

This study is sponsored by Omada Health, Inc. M.P. and C.M.C.S. are employees of the study sponsor. F.C., W.S., T.M.D., and S.H.B. provide paid consulting services to the study sponsor for this and other research. A.L.P. is a scientific advisor to the study sponsor and receives stock options from the study sponsor. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1. Model Overview Diagram.
Fig 1. Model Overview Diagram.
Fig 2. Projected Average Return On Investment…
Fig 2. Projected Average Return On Investment of Population with Prediabetes On Digital Intensive Behavioral Counseling Program Participation.
Fig 3. Projected Average Return On Investment…
Fig 3. Projected Average Return On Investment of CVD Risk Factor Population On Digital Intensive Behavioral Counseling Program Participation.
Fig 4. Projected 10-Year Cumulative Health Expenditures,…
Fig 4. Projected 10-Year Cumulative Health Expenditures, Digital Intensive Behavioral Counseling Program.

References

    1. Diabetes Prevention Program Research Group (2015) Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 3: 866–875. S2213-8587(15)00291-0 [pii];10.1016/S2213-8587(15)00291-0
    1. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, et al., (2009) 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374: 1677–1686. S0140-6736(09)61457-4 [pii];10.1016/S0140-6736(09)61457-4
    1. LeFevre ML (2014) Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 161: 587–593. [pii];10.7326/M14-1796
    1. Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, et al., (2005) Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 28: 888–894. 28/4/888 [pii].
    1. Siu AL (2015) Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. [pii];10.7326/M15-2345
    1. Sumamo E, Ha C, Korownyk C, Vandermeer B, Dryden DM (2011) Lifestyle Interventions for Four Conditions: Type 2 Diabetes, Metabolic Syndrome, Breast Cancer, and Prostate Cancer. Available: .
    1. McGill HC Jr., McMahan CA (1998) Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol 82: 30T–36T.
    1. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837–1847. 10.1161/01.CIR.97.18.1837
    1. Felix HC, West DS (2013) Effectiveness of weight loss interventions for obese older adults. Am J Health Promot 27: 191–199. 10.4278/ajhp.110617-LIT-259
    1. Kitzman DW, Brubaker P, Morgan T (2016) Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: A randomized clinical trial. Jama 315: 36–46. 10.1001/jama.2015.17346
    1. Centers for Disease Control and Prevention (2014) National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Available: .
    1. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K (2011) The impact of the aging population on coronary heart disease in the United States. Am J Med 124: 827–833. S0002-9343(11)00295-6 [pii];10.1016/j.amjmed.2011.04.010
    1. Sepah SC, Jiang L, Peters AL (2015) Long-term outcomes of a Web-based diabetes prevention program: 2-year results of a single-arm longitudinal study. J Med Internet Res 17: e92 v17i4e92 [pii];10.2196/jmir.4052
    1. Su W, Chen F, Dall TM, Iacobucci W, Perreault L (2016) Return on Investment for Digital Behavioral Counseling in Patients With Prediabetes and Cardiovascular Disease. Prev Chronic Dis 13: E13 10.5888/pcd13.150357; E13 [pii].
    1. Sepah SC, Jiang L, Peters AL (2014) Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards. Diabetes Educ 40: 435–443. 0145721714531339 [pii];10.1177/0145721714531339
    1. Moin T, Ertl K, Schneider J, Vasti E, Makki F, Richardson C, et al., (2015) Women veterans' experience with a web-based diabetes prevention program: a qualitative study to inform future practice. J Med Internet Res 17: e127 v17i5e127 [pii];10.2196/jmir.4332
    1. Centers for Disease Control and Prevention (CDC) (2015) Centers for Disease Control and Prevention Diabetes Prevention Recognition Program: Standards and Operating Procedures. Available: .
    1. Su W, Huang J, Chen F, Iacobucci W, Mocarski M, Dall TM, et al., (2015) Modeling the clinical and economic implications of obesity using microsimulation. J Med Econ 18: 886–897. 10.3111/13696998.2015.1058805
    1. Dall TM, Storm MV, Semilla AP, Wintfeld N, O'Grady M, Narayan KM (2015) Value of lifestyle intervention to prevent diabetes and sequelae. Am J Prev Med 48: 271–280. S0749-3797(14)00580-7 [pii];10.1016/j.amepre.2014.10.003
    1. Semilla AP, Chen F, Dall TM (2015) Reductions in mortality among Medicare beneficiaries following the implementation of Medicare Part D. Am J Manag Care 21: s165–s171. 86231 [pii].
    1. Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, et al., (2011) Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 377: 1341–1352. S0140-6736(11)60205-5 [pii];10.1016/S0140-6736(11)60205-5
    1. Heianza Y, Arase Y, Fujihara K, Hsieh SD, Saito K, Tsuji H, et al., (2012) Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes: the Toranomon Hospital Health Management Center Study 7 (TOPICS 7). Diabetes Care 35: 1050–1052. dc11-1793 [pii];10.2337/dc11-1793
    1. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM (2003) Influence of weight reduction on blood pressure a meta-analysis of randomized controlled trials. Hypertension 42: 878–884. 10.1161/
    1. Wilson PW, Anderson KM, Harri T, Kannel WB, Castelli WP (1994) Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. Journal of gerontology 49: M252–M257. 10.1093/geronj/49.6.M252
    1. Wing RR (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 170: 1566–1575. 170/17/1566 [pii];10.1001/archinternmed.2010.334
    1. Clarke PM, Gray AM, Briggs A, Farmer AJ, Fenn P, Stevens RJ, et al., (2004) A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 47: 1747–1759. 10.1007/s00125-004-1527-z
    1. Anderson KM, Odell PM, Wilson PW, Kannel WB (1991) Cardiovascular disease risk profiles. American heart journal 121: 293–298. 10.1016/0002-8703(91)90861-B
    1. Nichols GA, Reinier K, Chugh SS (2009) Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes care 32: 1851–1856. 10.2337/dc09-0939
    1. Hippisley-Cox J, Coupland C (2010) Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney-Scores. BMC family practice 11: 49 10.1186/1471-2296-11-49
    1. Kannel WB, Wolf PA, Benjamin EJ, Levy D (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. The American journal of cardiology 82: 2N–9N.
    1. Kannel WB WPGRJ (1987) The Framingham Study: An Epidemiological Intervention of Cardiovascular Diseases: Section 34: Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study 30 Year Followup.
    1. Wilson PW, Bozeman SR, Burton TM, Hoaglin DC, Ben-Joseph R, Pashos CL (2008) Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation 118: 124–130. 10.1161/CIRCULATIONAHA.108.772962
    1. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88: 107–115. 10.1161/01.CIR.88.1.107
    1. D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al., (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 117: 743–753.10.1161/CIRCULATIONAHA.107.699579
    1. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88: 107–115. 10.1161/01.CIR.88.1.107
    1. National Cancer Institute (2011) Annualized Mean Net Costs of Care. Available: .
    1. Faes C, Molenberghs G, Hens N, Muller A, Goossens H, Coenen S (2011) Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis. J Antimicrob Chemother 66 Suppl 6: vi89–vi94. dkr461 [pii];10.1093/jac/dkr461
    1. Kaiser Family Foundation (2014) How Much Is Enough? Out-of-Pocket Spending Among Medicare Beneficiaries: A Chartbook. Available:
    1. Congressional Budget Office (2015) March 2015 Medicare baseline. Available:
    1. Thorpe KE, Yang Z, Long KM, Garvey WT (2013) The impact of weight loss among seniors on Medicare spending. Health Econ Rev 3: 7 2191-1991-3-7 [pii];10.1186/2191-1991-3-7

Source: PubMed

3
Iratkozz fel